Literature DB >> 29441730

Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology.

David J Potter1, Kathy Hammond1, Shaun Tuffnell1, Christopher Walker2, Marta Di Forti3.   

Abstract

In 2005 and 2008, studies reported that cannabis in England had become dominated by the sinsemilla (unseeded female) form. The average potency (Δ9 -tetrahydrocannabinol [THC] content) of this material had doubled over the previous decade. Cannabis resin then circulating contained approximately equal ratios of THC and cannabidiol (CBD), whereas sinsemilla was almost devoid of CBD. Despite raised health concerns regarding sinsemilla use and the development of psychotic disorders, no update on street cannabis potency has been published since 2008. A total of 995 seized cannabis samples were acquired from the same 5 constabulary areas included in the 2005 study. The differing forms were segregated, and a representative 460 samples analyzed to assess their cannabinoid content using gas chromatography. The resultant median sinsemilla potency of 14.2% THC was similar to that observed in 2005 (13.9%). In each case, sinsemilla contained minimal CBD. Compared with 2005, resin had significantly higher mean THC (6.3%) and lower CBD (2.3%) contents (p < 0.0001). Although the average THC concentration in sinsemilla samples across the 5 constabularies has remained stable since 2005, the availability of this potent form of cannabis has further increased. Moreover, the now rarer resin samples show significantly decreased CBD contents and CBD:THC ratios, leaving the United Kingdom's cannabis street market populated by high-potency varieties of cannabis, which may have concerning implications for public health.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cannabidiol; cannabinoid; potency; psychosis; Δ9-tetrahydrocannabinol

Mesh:

Substances:

Year:  2018        PMID: 29441730     DOI: 10.1002/dta.2368

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  21 in total

1.  Cannabis in primary care.

Authors:  Leon Barron; Dani Gordon
Journal:  Br J Gen Pract       Date:  2019-11-28       Impact factor: 5.386

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

Review 3.  Acidic Cannabinoid Decarboxylation.

Authors:  Crist N Filer
Journal:  Cannabis Cannabinoid Res       Date:  2021-09-22

4.  Cannabis Use for Endometriosis: Clinical and Legal Challenges in Australia and New Zealand.

Authors:  Justin Sinclair; Yasmine Toufaili; Sarah Gock; Amanda G Pegorer; Jordan Wattle; Martin Franke; Muayed A K M Alzwayid; Jason Abbott; David W Pate; Jerome Sarris; Mike Armour
Journal:  Cannabis Cannabinoid Res       Date:  2021-12-31

5.  Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults.

Authors:  Natasha E Wade; Rachel Baca; Kelly E Courtney; Connor J McCabe; M Alejandra Infante; Marilyn A Huestis; Joanna Jacobus
Journal:  J Int Neuropsychol Soc       Date:  2021-07       Impact factor: 2.892

Review 6.  Cannabis, Cannabidiol Oils and Tetrahydrocannabinol-What Do Veterinarians Need to Know?

Authors:  Nancy De Briyne; Danny Holmes; Ian Sandler; Enid Stiles; Dharati Szymanski; Sarah Moody; Stephan Neumann; Arturo Anadón
Journal:  Animals (Basel)       Date:  2021-03-20       Impact factor: 2.752

7.  Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.

Authors:  Diego Quattrone; Laura Ferraro; Giada Tripoli; Caterina La Cascia; Harriet Quigley; Andrea Quattrone; Hannah E Jongsma; Simona Del Peschio; Giusy Gatto; Charlotte Gayer-Anderson; Peter B Jones; James B Kirkbride; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Sarah Tosato; Antonio Lasalvia; Andrei Szöke; Celso Arango; Miquel Bernardo; Julio Bobes; Cristina Marta Del Ben; Paulo Rossi Menezes; Pierre-Michel Llorca; Jose Luis Santos; Julio Sanjuán; Andrea Tortelli; Eva Velthorst; Lieuwe de Haan; Bart P F Rutten; Michael T Lynskey; Tom P Freeman; Pak C Sham; Alastair G Cardno; Evangelos Vassos; Jim van Os; Craig Morgan; Ulrich Reininghaus; Cathryn M Lewis; Robin M Murray; Marta Di Forti
Journal:  Psychol Med       Date:  2020-03-18       Impact factor: 7.723

8.  Adverse effects of heavy cannabis use: even plants can harm the brain.

Authors:  Lucia Sideli; Giulia Trotta; Edoardo Spinazzola; Caterina La Cascia; Marta Di Forti
Journal:  Pain       Date:  2021-07-01       Impact factor: 6.961

Review 9.  Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence.

Authors:  Grace Blest-Hopley; Marco Colizzi; Vincent Giampietro; Sagnik Bhattacharyya
Journal:  Front Psychiatry       Date:  2020-08-26       Impact factor: 4.157

10.  Increasing potency and price of cannabis in Europe, 2006-16.

Authors:  Tom P Freeman; Teodora Groshkova; Andrew Cunningham; Roumen Sedefov; Paul Griffiths; Michael T Lynskey
Journal:  Addiction       Date:  2019-01-16       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.